Equities

Key statistics

On Monday, Pfizer Inc (PFE:NYQ) closed at 41.89, -9.86% below its 52-week high of 46.47, set on Dec 04, 2018.
52-week range
Today
34.32Mar 26 201846.47Dec 04 2018
Markit short selling activity
Low
Med
High
Open41.81
High42.15
Low41.67
Bid--
Offer--
Previous close41.85
Average volume27.17m
Shares outstanding5.55bn
Free float5.55bn
P/E (TTM)24.35
Market cap232.34bn USD
EPS (TTM)1.72
USD
Annual div (ADY)1.44
USD
Annual div yield (ADY)3.44%
Div ex-dateJan 31 2019
Div pay-dateMar 01 2019
Data delayed at least 15 minutes, as of Mar 25 2019 20:01 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Pfizer Inc shares was Hold at 4,299.00 on 02 Jun 2014Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.